Independent fund research. Built on SEC filings.

How we research funds

Fund comparison

FBT vs. PBE: which is better?

Bottom line

FBT vs PBE: the short answer

FBT (First Trust NYSE Arca Biotechnology Index Fund) and PBE (Invesco Biotechnology & Genome ETF) share a meaningful slice of their top holdings — about 43% by weight.

FBT is cheaper at 0.55% vs 0.59% — a difference of $4.00 a year per $10,000 invested.

Over five years, FBT returned +4.3% a year vs +3.4% for PBE.

Updated Nov 19, 2026

FBT vs PBE side by side

FBTPBE
TypeETFETF
Fund familyFirst TrustInvesco
CategoryTechnology SectorTechnology Sector
Expense ratio0.55%0.59%
Annual cost per $10k$55$59
10-yr cost on $10k (prospectus)—$738
Max front loadNoneNone
12b-1 fee0%—
1-yr return+24.1%+24.7%
5-yr return (annualized)+4.3%+3.4%
10-yr return (annualized)+6.3%+5.2%
Best quarter+27.8%+25.3%
Worst quarter−22.5%−24.3%
Net assets (fund)$2.8B$281.9M
Number of holdings3233
Portfolio turnover37%103%
Returns as ofDec 31, 2025Dec 31, 2025

Source: SEC Form N-PORT and fund prospectuses

Year-by-year returns

YearFBTPBEDifference
2025+24.1%+24.7%−0.6%
2024+5.8%+1.1%+4.7%
2023+2.3%+3.7%−1.4%
2022−4.6%−10.8%+6.2%
2021−3.6%+1.6%−5.2%
2020+12.9%+25.5%−12.6%
2019+19.8%+18.3%+1.5%
2018−0.2%+0.2%−0.4%
2017+37.0%+22.4%+14.6%
2016−19.6%−23.0%+3.4%

Source: Fund prospectus bar charts

Holdings overlap

14 of FBT's top 25 holdings also appear in PBE's top 25.

Shared top holdings
HoldingFBTPBE
Veracyte Inc5.10%2.60%
Illumina Inc3.92%3.51%
Neurocrine Biosciences Inc3.53%2.66%
Bio-techne Corp3.43%3.73%
Biogen Inc3.37%4.79%
Exelixis Inc3.32%2.64%
Incyte Corp3.18%3.06%
Halozyme Therapeutics Inc3.11%2.98%
Vertex Pharmaceuticals Inc3.07%4.99%
Repligen Corp3.07%3.04%
Biomarin Pharmaceutical Inc2.83%2.82%
Amgen Inc2.78%5.22%
United Therapeutics Corp2.56%4.08%
Alnylam Pharmaceuticals Inc2.52%3.17%

Source: SEC Form N-PORT

FBT top 10

  1. Corcept Therapeutics Inc — 5.60%
  2. Neogenomics Inc — 5.12%
  3. Veracyte Inc — 5.10%
  4. Bruker Corp — 4.32%
  5. Alkermes Plc — 4.24%
  6. Illumina Inc — 3.92%
  7. Krystal Biotech Inc — 3.87%
  8. Natera Inc — 3.79%
  9. Axsome Therapeutics Inc — 3.71%
  10. Neurocrine Biosciences Inc — 3.53%

PBE top 10

  1. Invesco Private Prime Fund — 12.89%
  2. Regeneron Pharmaceuticals, Inc. — 5.47%
  3. Amgen Inc. — 5.22%
  4. CareDx, Inc. — 5.04%
  5. Vertex Pharmaceuticals Inc. — 4.99%
  6. Invesco Private Government Fund — 4.97%
  7. Royalty Pharma PLC — 4.94%
  8. Biogen Inc. — 4.79%
  9. Gilead Sciences, Inc. — 4.43%
  10. United Therapeutics Corp. — 4.08%

FAQ

What is the difference between FBT and PBE?
FBT (First Trust NYSE Arca Biotechnology Index Fund) and PBE (Invesco Biotechnology & Genome ETF) share a meaningful slice of their top holdings — about 43% by weight. FBT is cheaper at 0.55% vs 0.59% — a difference of $4.00 a year per $10,000 invested.
Which is cheaper, FBT or PBE?
FBT has the lower expense ratio (0.55%).
Should I own both FBT and PBE?
Because their portfolios differ, owning both can add diversification — check how they fit your overall allocation.

Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.